GAO says FDA is too lax on DTC ads policing

Share this article:
The Government Accountability Office ripped the FDA for lax policing of DTC advertising, saying the agency was slow to act on dubious drug ads due to inconsistent standards and bureaucratic snafus. “We believe that regulatory letters should be issued more quickly,” said the GAO's report.

Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.